Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells

PURPOSE: Oxaliplatin is a third-generation platinum compound, and it has no nephrotoxicity and has reduced bone marrow toxicity. Cancer cells that are resistant to cisplatin are sensitive to oxaliplatin. Oxaliplatin is used widely for the treatment of colon cancers. Recently, oxaliplatin was reporte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sohn, Won Jun, Lee, Jung Won, Park, Dong-Guk
Format: Artigo
Idioma:Inglês
Publicat: The Korean Society of Coloproctology 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2998014/
https://ncbi.nlm.nih.gov/pubmed/21152225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2010.26.4.246
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars